-
Something wrong with this record ?
Mucoadhesive plasticized system of branched poly(lactic-co-glycolic acid) with aciclovir
E. Snejdrova, M. Drastik, M. Dittrich, P. Kastner, J. Nguyenova,
Language English Country England, Great Britain
Document type Journal Article
- MeSH
- Acyclovir administration & dosage chemistry MeSH
- Biocompatible Materials chemistry MeSH
- Time Factors MeSH
- Hydrophobic and Hydrophilic Interactions MeSH
- Lactic Acid chemistry MeSH
- Polyglycolic Acid chemistry MeSH
- Delayed-Action Preparations MeSH
- Surface Properties MeSH
- Drug Liberation MeSH
- Particle Size MeSH
- Plasticizers administration & dosage chemistry MeSH
- Publication type
- Journal Article MeSH
Commercially available antibacterial semisolid preparations intended for topical application provide only short-term drug release. A sustained kinetics is possible by exploitation of a biodegradable polymer carrier. The purpose of this work is to formulate a mucoadhesive system with aciclovir (ACV) based on a solid molecular dispersion of this drug in poly(lactic-co-glycolic acid) branched on tripenterythritol (PLGA/T). The ACV incorporation into PLGA/T was carried out either by solvent method, or melting method, or plasticization method using various plasticizers. The drug-polymer miscibility, plasticizer efficiency and content of residual solvent were found out employing DSC. Viscosity was measured at the shear rate range from 0.10 to 10.00 s(-1) at three temperatures and data were analyzed by Newtonian model. The mucoadhesive properties were ascertained in the tensile test on a mucin substrate. The amount of ACV released was carried out in a wash-off dissolution test. The DSC results indicate a transformation of crystalline form of ACV into an amorphous dissolved in branched polyester carrier, and absence of methyl formate residuals in formulation. All the tested plasticizers are efficient at Tg depression and viscosity decrease. The non-conventional ethyl pyruvate possessing supportive anti-inflammatory activity was evaluated as the most suitable plasticizer. The ACV release was strongly dependent on the ethyl pyruvate concentration and lasted from 1 to 10 days. The formulated PLGA/T system with ACV exhibits increased adhesion to mucosal hydrophilic surfaces and prolonged ACV release controllable by degradation process and viscosity parameters.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17014069
- 003
- CZ-PrNML
- 005
- 20170428112245.0
- 007
- ta
- 008
- 170413s2016 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3109/03639045.2016.1160109 $2 doi
- 035 __
- $a (PubMed)26925606
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Snejdrova, Eva $u a Department of Pharmaceutical Technology , Charles University in Prague, Faculty of Pharmacy in Hradec Kralove, Czech Republic ;
- 245 10
- $a Mucoadhesive plasticized system of branched poly(lactic-co-glycolic acid) with aciclovir / $c E. Snejdrova, M. Drastik, M. Dittrich, P. Kastner, J. Nguyenova,
- 520 9_
- $a Commercially available antibacterial semisolid preparations intended for topical application provide only short-term drug release. A sustained kinetics is possible by exploitation of a biodegradable polymer carrier. The purpose of this work is to formulate a mucoadhesive system with aciclovir (ACV) based on a solid molecular dispersion of this drug in poly(lactic-co-glycolic acid) branched on tripenterythritol (PLGA/T). The ACV incorporation into PLGA/T was carried out either by solvent method, or melting method, or plasticization method using various plasticizers. The drug-polymer miscibility, plasticizer efficiency and content of residual solvent were found out employing DSC. Viscosity was measured at the shear rate range from 0.10 to 10.00 s(-1) at three temperatures and data were analyzed by Newtonian model. The mucoadhesive properties were ascertained in the tensile test on a mucin substrate. The amount of ACV released was carried out in a wash-off dissolution test. The DSC results indicate a transformation of crystalline form of ACV into an amorphous dissolved in branched polyester carrier, and absence of methyl formate residuals in formulation. All the tested plasticizers are efficient at Tg depression and viscosity decrease. The non-conventional ethyl pyruvate possessing supportive anti-inflammatory activity was evaluated as the most suitable plasticizer. The ACV release was strongly dependent on the ethyl pyruvate concentration and lasted from 1 to 10 days. The formulated PLGA/T system with ACV exhibits increased adhesion to mucosal hydrophilic surfaces and prolonged ACV release controllable by degradation process and viscosity parameters.
- 650 _2
- $a acyklovir $x aplikace a dávkování $x chemie $7 D000212
- 650 _2
- $a biokompatibilní materiály $x chemie $7 D001672
- 650 _2
- $a léky s prodlouženým účinkem $7 D003692
- 650 _2
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a hydrofobní a hydrofilní interakce $7 D057927
- 650 _2
- $a kyselina mléčná $x chemie $7 D019344
- 650 _2
- $a velikost částic $7 D010316
- 650 _2
- $a změkčovadla $x aplikace a dávkování $x chemie $7 D010968
- 650 _2
- $a kyselina polyglykolová $x chemie $7 D011100
- 650 _2
- $a povrchové vlastnosti $7 D013499
- 650 _2
- $a časové faktory $7 D013997
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Drastik, Martin $u b Department of Biophysics and Physical Chemistry , Charles University in Prague, Faculty of Pharmacy in Hradec Kralove, Czech Republic ;
- 700 1_
- $a Dittrich, Milan $u a Department of Pharmaceutical Technology , Charles University in Prague, Faculty of Pharmacy in Hradec Kralove, Czech Republic ;
- 700 1_
- $a Kastner, Petr $u c Department of Pharmaceutical Chemistry and Drug Control , Charles University in Prague, Faculty of Pharmacy in Hradec Kralove, Czech Republic.
- 700 1_
- $a Nguyenova, Jana $u a Department of Pharmaceutical Technology , Charles University in Prague, Faculty of Pharmacy in Hradec Kralove, Czech Republic ;
- 773 0_
- $w MED00001439 $t Drug development and industrial pharmacy $x 1520-5762 $g Roč. 42, č. 10 (2016), s. 1653-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26925606 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20170428112606 $b ABA008
- 999 __
- $a ok $b bmc $g 1200534 $s 974847
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 42 $c 10 $d 1653-9 $e 20160317 $i 1520-5762 $m Drug development and industrial pharmacy $n Drug Dev Ind Pharm $x MED00001439
- LZP __
- $a Pubmed-20170413
